Fusion Investment Group’s AbbVie ABBV Stock Holding History

Fusion Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$361K	Sell	6,091 -1,952	-24%	-$112K	0.97%	36
2015 Q3	$437K	Sell	8,043 -892	-10%	-$58.1K	1.03%	35
2015 Q2	$601K	Buy	8,935 +6,119	+217%	+$399K	0.47%	52
2015 Q1	$165K	Buy	2,816 +460	+20%	+$27.8K	0.13%	90
2014 Q4	$154K	Sell	2,356 -1,982	-46%	-$125K	0.13%	91
2014 Q3	$251K	Sell	4,338 -26	-0.6%	-$1.44K	0.22%	69
2014 Q2	$247K	Buy	4,364 +4,120	+1,689%	+$216K	0.21%	78
2014 Q1	$13K	Sell	244 -4,484	-95%	-$227K	0.01%	177
2013 Q4	$250K	Buy	+4,728	New	+$232K	0.18%	108

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fusion Investment Group's ABBV Position: Q4 2015 in Review

Fusion Investment Group reduced its AbbVie (ABBV) stake by 24% in Q4 2015, selling an estimated $112K and leaving 6,091 shares worth $361K. The position accounts for 0.97% of the portfolio, ranked #36.

Fusion Investment Group first reported a position in ABBV in Q4 2013 and has held it in 9 quarters since. The position peaked at $601K in Q2 2015. 1,636 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

Fusion Investment Group held 6,091 shares of AbbVie worth $361K as of Q4 2015.
Fusion Investment Group sold 1,952 AbbVie shares in Q4 2015, an estimated $112K.
AbbVie made up 0.97% of Fusion Investment Group's portfolio in Q4 2015, its #36 holding.
Fusion Investment Group first reported a position in AbbVie in Q4 2013 and has held it in 9 quarters since.
Fusion Investment Group's AbbVie position peaked at $601K in Q2 2015.
1,636 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on Fusion Investment Group's 13F filing for Q4 2015, filed 16 Feb 2016.